http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106278928-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2d347cf83d7791aa91ff4990cec87d2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
filingDate 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8df0ad286f6aba92800b9571e0a5d34a
publicationDate 2017-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106278928-A
titleOfInvention A kind of synthetic method of oseltamivir phosphate isomer impurity
abstract The invention belongs to the field of medicine and chemical industry, and specifically relates to a method for synthesizing oseltamivir phosphate isomer impurity (formula I). The main steps are: use the starting material of compound II to react with compound III under the catalysis of a chiral Lewis acid catalyst, filter off the catalyst and evaporate the solvent to dryness, then form a salt with an organic acid in a suitable solvent for purification, and decompose After separation, the compound IV was obtained, and then the amino protecting group was removed by hydrogenolysis to form a phosphate, and the target compound was obtained by purification. The identification, preparation and purification of the impurity provide a more effective means for the quality control of oseltamivir phosphate bulk drug.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109890790-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018233562-A1
priorityDate 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012010254-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009037137-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467854481

Total number of triples: 21.